Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee
Director, Pang Kuei Accounting Firm, Independent Director, Lin BioScience Inc., Independent Director, SINMAG EQUIPMENT CORPORATION, Independent Director, DAH CHUNG BILLS FINANCE CORP., Supervisor, JORJIN TECHNOLOGIES INC. Reason for the change: Additional appointment Cooperate with the general re-election of the shareholders' general meeting and re-appoint members of the Compensation Committee. Effective date of the new member January 16, 2024 too May 24, 2025.